The FDA has granted Fast Track designation for SAB Biotherapeutics' SABS SAB-176, an investigational therapeutic for Type A and Type B influenza illness in high-risk patients, including those who have ...

Stock Score Locked: Want to See it? Benzinga Rankings give you vital metrics on any stock – anytime.

Innocent Mayoyo, technical director of Ayoba, shaking hands with Alan Levin as a sign of their growing partnership. The team bought the Barcelorna FC status in the league and will be playing in the ...

SAB-142 shows favorable safety and pharmacodynamic activity in Phase 1 trial, advancing to Phase 2b for type 1 diabetes. SAB BIO announced positive results from its Phase 1 trial of SAB-142, a novel ...